We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Stem Cells Replace Stroke-Damaged Tissue in Lab Rats

By LabMedica International staff writers
Posted on 23 Mar 2009
Successful stem cell treatment for strokes has taken a significant step forward as scientists reveal how they have replaced stroke-damaged brain tissue in rats.

The team of scientists project is funded by the Biotechnology and Biological Sciences Research Council (BBSRC; Swindon, UK) and led by Dr. More...
Mike Modo of the Institute of Psychiatry, King's College London (UK). The study, performed at the Institute of Psychiatry and University of Nottingham (UK), shows that by inserting tiny scaffolding with stem cells attached, it is possible to fill a hole left by stroke damage with brand new brain tissue within seven days. The study was published in the March 2009 issue of the journal Biomaterials.

Earlier studies where stem cells have been injected into the void left by stroke damage have had some success in improving outcomes in rats. The difficulty is that in the damaged area there is no structural support for the stem cells and so they are apt to migrate into the surrounding healthy tissues instead of filling up the hole left by the stroke. Dr. Modo noted, "We would expect to see a much better improvement in the outcome after a stroke if we can fully replace the lost brain tissue, and that is what we have been able to do with our technique.”

Using individual particles of a biodegradable polymer called poly(lactide-co-glycolide) (PLGA) that have been loaded with neural stem cells, the team of scientists have filled stroke cavities with stem cells on a ready-made support structure. Dr. Modo continued, "This works really well because the stem cell-loaded PLGA particles can be injected through a very fine needle and then adopt the precise shape of the cavity. In this process the cells fill the cavity and can make connections with other cells, which helps to establish the tissue. Over a few days we can see cells migrating along the scaffold particles and forming a primitive brain tissue that interacts with the host brain. Gradually, the particles biodegrade, leaving more gaps and conduits for tissue, fibers, and blood vessels to move into.”

The research utilizes a magnetic resonance imaging (MRI) scanner to target precisely the correct place to inject the scaffold-cell structure. MRI is also used to monitor the development of the new brain tissue over time. The next stage of the study will be to include a factor called vascular endothelial growth factor (VEGF) with the particles. VEGF will encourage blood vessels to enter the new tissue.

Related Links:

King's College London
University of Nottingham
Biotechnology and Biological Sciences Research Council




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.